All Posts: News Release
-
$3.2 Million Grant Supports Study of New Genetic Testing Approach to Reduce Racial Health Disparities
The National Cancer Institute has awarded a $3.2 million grant to investigators from Georgetown University’s Lombardi Comprehensive Cancer Center and Rutgers Cancer Institute of New Jersey, both NCI-designated Comprehensive Cancer Centers, to examine a novel approach to genetic testing and care based on community-identified needs, with the aim of reducing racial disparity gaps in cancer care delivery.
Category: News Release
-
Study Finds Relationship Between Discrimination and Frailty in Black Cancer Survivors
Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for cancer survivors, according to a new study.
Category: News Release
-
Ron Rivera, Washington Commanders’ Coach, to Receive NFL Players Association Georgetown Lombardi Award
WASHINGTON (January 5, 2023) — Georgetown University’s Lombardi Comprehensive Cancer Center and the NFL Players Association are pleased to announce Washington Commanders Coach and cancer survivor Ron Rivera as the recipient of the 2023 NFLPA Georgetown Lombardi Award. The annual award recognizes a sports figure who has faced cancer and who possesses the qualities that […]
Category: News Release
-
Drug Found to be Effective in Difficult to Treat Autoimmune Blood Disorder
Category: News Release
-
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
WASHINGTON (Thursday, December 1, 2022) — While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce the risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues showed that these treatments could also reduce the risk of […]
Category: News Release
-
Study in Mice Suggests that Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention Strategies
WASHINGTON (December 1, 2022) — In a study using a first-of-its-kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive postmenopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues have determined that over-expression, or switching on, of the Esr1 gene could lead to elevated risk of developing estrogen receptor-positive breast […]
Category: News Release
-
BellRinger, Georgetown Lombardi Comprehensive Cancer Center’s Inaugural Bike Ride to End Cancer, Commences Saturday
WASHINGTON (October 20, 2022) — BellRinger, a bike ride and community movement, will commence its inaugural 25-, 50, and 100-mile fundraising ride this Saturday, October 22, with an opening ceremony to kick off festivities on Friday, October 21. BellRinger has registered more than 800 riders with the goal to raise over $1.4 million. Local cancer […]
Category: News Release
-
The Society for Immunotherapy of Cancer (SITC) Publishes a Checklist to Maximize the Benefit to Patients for Clinical Trials in Immuno-oncology
MILWAUKEE (October 6, 2022)— No uniform method has been established to predict the probability of success for individual clinical trials. To help identify clinical trials with a high likelihood of offering benefit to patients, the Society for Immunotherapy of Cancer (SITC) brought together a team of experts in immuno-oncology to create a conceptual framework for […]
Category: News Release
-
Long-term Study Supports Link Between Inflammation and Cognitive Problems in Older Breast Cancer Survivors
Researchers followed hundreds of survivors for years to examine suspected source of worrying symptoms. LOS ANGELES (September 30, 2022) — Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors, published today […]
Category: News Release
-
Advanced Melanoma Survival Improves Significantly When Immunotherapy is Given Before Targeted Therapy
The findings, coupled with results from another recent clinical trial, mark significant advances in the treatment of melanoma. WASHINGTON (September 27, 2022) — A clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall survival rate for people with advanced melanoma who first received […]
Category: News Release